FNAM (Evolutionary Genomics) Net Margin %: 0.00% (As of Dec. 2022)


FNAM Evolutionary Genomics Inc FNAM
31 GF Score
Price $0.00
View Full Analysis

What is Evolutionary Genomics Net Margin %?

Evolutionary Genomics FNAM 31 Net Margin % is 0.00% as of Dec. 2022. GuruFocus rates FNAM with a GF Score™ of 31/100.

Net margin is calculated as Net Income divided by its Revenue. Evolutionary Genomics's Net Income for the three months ended in Dec. 2022 was $-0.33 Mil. Evolutionary Genomics's Revenue for the three months ended in Dec. 2022 was $0.00 Mil. Therefore, Evolutionary Genomics's net margin for the quarter that ended in Dec. 2022 was 0.00%.

The historical rank and industry rank for Evolutionary Genomics's Net Margin % or its related term are showing as below:


FNAM's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.29
* Ranked among companies with meaningful Net Margin % only.

Evolutionary Genomics  (OTCPK:FNAM) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Evolutionary Genomics Net Margin % Related Terms

Evolutionary Genomics Net Margin % Historical Data

* Premium members only.

The historical data trend for Evolutionary Genomics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolutionary Genomics Net Margin % Chart

Evolutionary Genomics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -955.65 -644.72 -13,169.23 0.00 0.00

Evolutionary Genomics Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FNAM vs BXRX, GNCA, XSNX: Net Margin % Comparison

For the Biotechnology subindustry, Evolutionary Genomics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolutionary Genomics Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolutionary Genomics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Evolutionary Genomics's Net Margin % falls into.


FNAM
31GF Score
Evolutionary Genomics Inc FNAM
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evolutionary Genomics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Evolutionary Genomics's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-1.935/0
= %

Evolutionary Genomics's Net Margin for the quarter that ended in Dec. 2022 is calculated as

Net Margin=Net Income (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=-0.334/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Evolutionary Genomics (FNAM) has a Net Margin % of 0.00% as of Dec. 2022. Net margin is the ratio of total net income to net sales. View historical data on Evolutionary Genomics and its competitors.
Is Evolutionary Genomics' Net Margin % too high?
Evolutionary Genomics' current Net Margin % is 0.00%. Overall, Evolutionary Genomics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Evolutionary Genomics' Net Margin % compare to BXRX and GNCA?
Evolutionary Genomics' Net Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Evolutionary Genomics and its competitors. Evolutionary Genomics's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolutionary Genomics stock overvalued right now?
Evolutionary Genomics (FNAM) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Evolutionary Genomics' overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Evolutionary Genomics (FNAM), the current Net Margin % is 0.00% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evolutionary Genomics Business Description

Address 4220 Morning Star Drive, Castle Rock, CO, USA, 80108
Evolutionary Genomics Inc is involved in the development of a technology platform, the Adapted Traits Platform (ATP), to identify commercially valuable genes that control important traits in animals and plants. It uses the ATP to identify genes to improve crop plant traits such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. The company's platform identifies key genes that have changed successfully to impart new or improved traits. Its primary source of revenue had been contract services revenue for research performed by it on behalf of other commercial entities and grant income received from governmental agencies, industry associations and grant-making foundations for research performed.
31GF Score

Get the complete analysis for FNAM

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price